(Q40651854)

English

Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies

scientific article published on May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

antiphospholipid syndrome

1 reference

based on heuristic

inferred from title

4

object named as

Raoult D

1 reference

Europe PubMed Central

22 September 2017

author name string

Sanmarco M

1

1 reference

Europe PubMed Central

22 September 2017

Soler C

2

1 reference

Europe PubMed Central

22 September 2017

Christides C

3

1 reference

Europe PubMed Central

22 September 2017

Weiller PJ

5

1 reference

Europe PubMed Central

22 September 2017

Gerolami V

6

1 reference

Europe PubMed Central

22 September 2017

Bernard D

7

1 reference

Europe PubMed Central

22 September 2017

publication date

1 May 1997

1 reference

Europe PubMed Central

22 September 2017

Translational Research

1 reference

Europe PubMed Central

22 September 2017

129

1 reference

Europe PubMed Central

22 September 2017

5

1 reference

Europe PubMed Central

22 September 2017

499-506

1 reference

Europe PubMed Central

22 September 2017

Antiphospholipid antibodies and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

The antiphospholipid syndrome: a syndrome in evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Antiphospholipid syndrome within systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

'Primary', 'secondary' and other variants of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Cofactor dependent and cofactor independent anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Detection of anti-bovine beta 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Surface modification and evaluation of some commonly used catheter materials. I. Surface properties

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990004-4

7 January 2021

Identifiers

10.1016/S0022-2143(97)90004-4

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40651854&oldid=1904211488"